業績

• 2024年
• 2023年
• 2022年
• 2021年
• 2020年
• 2019年
• 2018年
• 2017年
• 2016年
• 2015年
• 2014年
• 2013年
• 2012年
• 2011年
• 2010年
• 2009年
• 2008年
• 2007年
• 2006年

2023年

• 原著
• 症例報告
• 総説

原著

• Tsuda S, Honda T, Higashioka M, Hata J, Nakano T, Kitazono T, Ninomiya T.

  Longitudinal association of sedentary time with diabetes mellitus and markers of glucose metabolism in middle-aged and older adults: The Hisayama Study.
  

  J Diabetes Investig 2024;15(2):245-246.

• Fujisawa H, Nakayama M, Haruyama N, Fukui A, Yoshitomi R, Tsuruya K, Nakano T, Kitazono T.

  Association between iron status markers and kidney outcome in patients with chronic kidney disease.

  Scientific Reports 2023;13(1):18278.

• Aihara S, Yamada S, Matsueda S, Nagashima A, Torisu K, Kitazono T, Nakano T.

  Magnesium inhibits peritoneal calcification as a late-stage characteristic of encapsulating peritoneal sclerosis.
  

  Sci Rep 2023:13(1):16340.

• Inoue M, Nakai K, Tanaka S, Mitsuiki K, Tokumoto M, Tsuruya K, Kitazono T, Nakano T.

  Prevalence of hyponatremia and associated factors in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry (FKR) study.
  

  Clin Exp Nephrol 2023;27(12):1023-1031.

• Hiyamuta H, Yamada S, Nakano T, Taniguchi M, Masutani K, Tsuruya K, Kitazono T.

  Impact of Electrocardiographic Parameters on Sudden Death in Patients Receiving Maintenance Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study.
  

  J Atheroscler Thromb 2024;31(3):214-231.

• Shukuri T, Nakai K, Tanaka S, Yamada S, Tokumoto M, Tsuruya K, Nakano T, Kitazono T.

  Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study.
  

  Clin Exp Nephrol 2023;27(11):919-927.

• Uchida Y, Torisu K, Aihara S, Imazu N, Ooboshi H, Kitazono T, Nakano T.

  Arginase 2 Promotes Cisplatin-Induced Acute Kidney Injury by the Inflammatory Response of Macrophages.

  Lab Invest 2023;103(10):100227.

• Uchida Y, Nakano T, Hiyamuta H, Kitamura H, Taniguchi M, Ooboshi H, Tsuruya K, Kitazono T.

  Association between Serum C-Reactive Protein Concentrations and Risk of Cancer-Related Mortality in Patients Undergoing Hemodialysis: 10-Year Outcomes of the Q-Cohort Study.

  Blood Purif 2023 Jun 16:1-8.

• Aihara S, Torisu K, Hirashima Y, Kitazono T, Nakano T.

  Acrolein produced during acute kidney injury promotes tubular cell death.
  

  Biochem Biophys Res Commun. 2023 Jul 23;666:137-145.

• Haruyama N, Nakayama M, Fukui A, Yoshitomi R, Tsuruya K, Nakano T, Kitazono T.

  Sex differences in the association between urate metabolism and kidney outcomes in patients with chronic kidney disease.

  Clin Exp Nephrol in press

• Nagae H, Ueno Y, Shojima M, Takae K, Kuroki Y, Katafuchi R.

  Risk factor for progression to kidney failure with replacement therapy in elderly patients with chronic kidney disease: A retrospective single-centre cohort study.
  
  

  Nephrology (Carlton). 2023 Jun;28(6):336-344.

• Kishimoto H, Nakano T, Torisu K, Tokumoto M, Uchida Y, Yamada S, Taniguchi M, Kitazono T.

  Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway.

  Front Cardiovasc Med. 2023 Feb 21;10:990422.

• Nakagawa K, Tanaka S, Tsuruya K, Kitazono T, Nakano T.

  Association between microscopic hematuria and albuminuria in patients with chronic kidney disease caused by diabetes and hypertension: the Fukuoka Kidney disease Registry Study.

  Clin Exp Nephrol 2023 Mar;27(3):227-235.

• Yamada S, Arase H, Taniguchi M, Kitazono T, Nakano T.

  Simplified geriatric nutritional risk index for assessing nutritional status and stratifying mortality risk in patients receiving maintenance hemodialysis.

  Ther Apher Dial. 2023 Apr;27(2):253-263.

• Seki M, Nakano T, Tanaka S, Matsukuma Y, Funakoshi K, Ohkuma T, Kitazono T.

  Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD).

  Clin Exp Nephrol. 2023 Apr;27(4):358-364.

• Kitamura H, Tanaka S, Hiyamuta H, Shimamoto S, Tsuruya K, Nakano T, Kitazono T; FKR Study Collaboration Group.

  Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional Study

  Journal of Atherosclerosis and Thrombosis in press

• Yamada S, Tanaka S, Arase H, Hiyamuta H, Kitamura H, Tokumoto M, Mitsuiki K, Tsuruya K, Kitazono T, Nakano T.

  Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study.

  Clin Exp Nephrol. 2023 Feb;27(2):151-160.

• Uchida Y, Nakano T, Kitamura H, Taniguchi M, Tsuruya K, Kitazono T.

  Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study.
  

  Clin Exp Nephrol 2023;27(1):79-88.

• Tsuda S, Nakayama M, Tanaka S, Haruyama N, Yoshitomi R, Fukui A, Tsuruya K, Nakano T, Kitazono T.

  The Association of Controlling Nutritional Status Score and Prognostic Nutritional Index with Cardiovascular Diseases: the Fukuoka Kidney Disease Registry Study.

  J Atheroscler Thromb. 2023 Apr 1;30(4):390-407.

症例報告

• Yamada S, Kitazono T, Nakano T.

  Successful treatment with anti-tuberculous drugs and zoledronate of hypercalcemia due to calcitriol overproduction in a patient undergoing maintenance dialysis complicated by tuberculous pleuritis.
  

  Ther Apher Dial in press

• Takae K, Ueno Y, Shojima M, Nagae H, Nakano T, Takata S, Katafuchi R, Masutani K, Nakano T, Kuroki Y.

  A case of acute kidney injury due to native kidney BK polyomavirus-associated nephropathy in a human T-lymphotropic virus type 1 carrier.

  BMC Nephrol. 2023 Oct 31;24(1):323.

• Yamada S, Takesako M, Kitazono T, Nakano T.

  Normalization of progressive increases in serum myeloperoxidase-anti-neutrophil cytoplasmic antibody titers after breast cancer resection in a patient with clinically stable microscopic polyangiitis.
  

  CEN Case Rep In Press

総説

• Yamada S, Nakano T.

  Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD.
  

  J Atheroscler Thromb.

• Nakano T, Kishimoto H, Tokumoto M.

  Direct and indirect effects of fibroblast growth factor 23 on the heart (review).

  Front Endocrinol (Lausanne). 2023 Feb 24;14:1059179.